INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 223 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $760 | -45.5% | 1,702 | 0.0% | 0.00% | -100.0% |
| Q1 2023 | $1,395 | -47.4% | 1,702 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $2,654 | -11.5% | 1,702 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $3,000 | 0.0% | 1,702 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $3,000 | +50.0% | 1,702 | +150.3% | 0.00% | +100.0% |
| Q1 2022 | $2,000 | -33.3% | 680 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $3,000 | -66.7% | 680 | -29.5% | 0.00% | -66.7% |
| Q2 2021 | $9,000 | 0.0% | 965 | 0.0% | 0.01% | -25.0% |
| Q1 2021 | $9,000 | +50.0% | 965 | +41.9% | 0.01% | +60.0% |
| Q4 2020 | $6,000 | -33.3% | 680 | -12.8% | 0.01% | -44.4% |
| Q3 2020 | $9,000 | -50.0% | 780 | +14.7% | 0.01% | -55.0% |
| Q2 2020 | $18,000 | – | 680 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 581,100 | $2,324,000 | 2.21% |
| Round Table Services, LLC | 339,391 | $1,358,000 | 0.52% |
| ARK Investment Management | 1,885,641 | $7,543,000 | 0.31% |
| WASATCH ADVISORS LP | 5,337,930 | $21,352,000 | 0.28% |
| Cedar Brook Financial Partners, LLC | 41,500 | $166,000 | 0.10% |
| Unified Trust Company, N.A. | 13,716 | $54,000 | 0.05% |
| Virtus ETF Advisers LLC | 60,398 | $242,000 | 0.04% |
| OXFORD ASSET MANAGEMENT LLP | 394,703 | $1,579,000 | 0.04% |
| FOX RUN MANAGEMENT, L.L.C. | 14,465 | $58,000 | 0.03% |
| BREWIN DOLPHIN LTD | 59,123 | $236,492 | 0.03% |